There are 2 papers on pAD in aging research: 1 observational study in people.
2 papers study it7 findings
“The p AD hazard ratios [95% CI] were 3.58 [2.79,4.61], 4.67 [3.46,6.30] and 4.35 [3.34,5.67] for models trained on NACC, ADNI and both datasets respectively”
- Humans1
- In silico1
Upstream
3Amyloid
upin humans1
1 study
Amyloid
upin humans1
Amyloid is linked with higher pAD in patients with aMCI (2.40 ± 5.25 vs 0.93 ± 5.20; P = .003).
“patients with amyloid-positive aMCI were observed to have higher PADs than patients with amyloid-negative status”
Humansin patients with aMCI
Radiology. Artificial intelligence
APOE
upin humans1
1 study
APOE
upin humans1
APOE is linked with higher pAD in patients with aMCI (3.76 ± 4.82 vs 0.10 ± 5.05; P = .017).
“apolipoprotein E ε4 allele carriers were observed to have higher PADs than noncarriers”
Humansin patients with aMCI
Radiology. Artificial intelligence
Amnestic mild cognitive impairment
upin humans1
1 study
Amnestic mild cognitive impairment
upin humans1
Amnestic mild cognitive impairment is linked with higher pAD in humans (patients with aMCI vs healthy controls) (BABRI: 2.65 ± 4.91 vs 0.18 ± 4.79 (P < .001); ADNI: 1.68 ± 5.28 vs 0.05 ± 4.41 (P < .001)).
“patients with aMCI were found to have higher PADs than those of healthy controls”
Humanspatients with aMCI vs healthy controls
Radiology. Artificial intelligence
Associations
3Dementia
upin humans1HR 3.58
1 study
Dementia
upin humans1HR 3.58
pAD is linked with a higher risk of dementia in humans (13.6%-16.7% increased risk per 0.1 increase).
“with a 0.1 increase in p AD equating to a 13.6%‐16.7% increased risk of receiving a dementia diagnosis within 8 years.”
Humansbrainwithin 8 yearsn = 1,140
AAIC 2025 abstract
pAD predicts dementia in humans (models trained on NACC, ADNI and both datasets respectively) (HR 3.58 [2.79, 4.61]).
“The p AD hazard ratios [95% CI] were 3.58 [2.79,4.61], 4.67 [3.46,6.30] and 4.35 [3.34,5.67] for models trained on NACC, ADNI and both datasets respectively”
Humansmodels trained on NACC, ADNI and both datasets respectivelybrain8 yearsn = 1,140
AAIC 2025 abstract
Clinical progression
upin humans1
1 study
Clinical progression
upin humans1
pAD predicts clinical progression in humans (for differentiating between progressive and stable aMCI) (AUC 0.87).
“PAD combined with other markers of AD at baseline for differentiating between progressive and stable aMCI resulted in an area under the curve value of 0.87”
Humansfor differentiating between progressive and stable aMCI
Radiology. Artificial intelligence
Cognitive impairment
upin humans1
1 study
Cognitive impairment
upin humans1
pAD is associated with cognitive impairment in patients with aMCI (P < .05, corrected).
“the PAD was significantly associated with individual cognitive impairment in several cognitive domains in patients with aMCI”
Humansin patients with aMCI
Radiology. Artificial intelligence
Funding
21 grants since 2017National Heart, Lung, and Blood Institute$7.5MNational Institute on Aging$5MUS Department of Veterans Affairs
Japan Society for the Promotion of ScienceSaitama Prefectural University¥4.6M2026–2030
National Institute for Health ResearchPlymouth University£458K2025–2028
UKRI | Medical Research CouncilUniversity of Liverpool£335K2023–2025
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD
National Institute on AgingNorthwestern University$723K2022–2027
Japan Society for the Promotion of ScienceWaseda University¥2.9M2022–2025
FIsetin to Reduce Senescence and mobility impairmenT in PAD: the FIRST Pilot Randomized Trial
National Institute on AgingNorthwestern University$223K2022–2024
INTERmittent pneumatic ComprEssion for Disability rEversal in PAD: the INTERCEDE Trial
National Institute on AgingNorthwestern University$608K2018–2025
2/2 PROmote weight loss in obese PAD patients to preVEnt mobility loss: The PROVE Trial--DCC
National Heart, Lung, and Blood InstituteWake Forest University Health Sciences$95.8K2019–2025
1/2 + PROmote weight loss in obese PAD patients to preVEnt mobility loss: the PROVE Trial
National Heart, Lung, and Blood InstituteNorthwestern University$652K2019–2025
Exercise and Weight Loss to Improve Mobility Function in Veterans with PAD
US Department of Veterans AffairsBaltimore Va Medical Center2016–2022
Contains public sector information licensed under the Open Government Licence v3.0.